The Company reported net income of approximately $283,000 or $0.03 per basic and diluted common share for the three months ended February 28, 2025, compared to net income of approximately $556,000, or ...

About Cryo-Cell International Inc. Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates ...

Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks Cryo-Cell International, Inc. (NYSE ...

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, ...

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange ...

(RTTNews) - Private cord blood bank Cryo-Cell International, Inc. (CCEL) announced Monday that its Board of Directors has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the ...

Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the NYSE American LLC (the ...

The membrane that surrounds cells in living organisms is extremely flexible and sensitive. How it protects itself from damage and renews itself is crucial for many life processes, and is not yet fully ...